Vertex Pharmaceuticals, Inc.

NASDAQ:VRTX  
287.24
+5.45 (+1.93%)
Products

Vertex Pharmaceuticals Announces Inaxaplin Granted Breakthrough Therapy Designation By U.S. FDA And Priority Medicines (Prime) Designation By The EMA

Published: 06/08/2022 13:15 GMT
Vertex Pharmaceuticals, Inc. (VRTX) - Vertex Announces Inaxaplin (vx-147) Granted Breakthrough Therapy Designation by U.S. FDA and Priority Medicines (prime) Designation by the Ema.